Professional Documents
Culture Documents
Biguanide Name of Drug Metformin (Glucophage) Now available in tablet and powder form Dose 500 mg 850 mg 1000 mg Max Dose 1g TDS Typical Dose is 1g BD Time of Administration Once, twice or three times daily with food Side Effects GI upset B12 deficiency Precaution Renal impairment Cirrhotic liver disease Acute CCF Metabolic acidosis Lactic acidosis Contrast studies* Renal impairment Liver impairment
Sulphonylureas
30 mg 80 mg 1 2 3 4 5 mg mg mg mg mg
Once daily - with breakfast Once / twice daily, with food - breakfast and evening meal Once daily - with breakfast
Hypoglycaemia GI upset
Glipizide (Glibenese)
Thiazolidinedione (TZD)
2.5 mg 5 mg 15 mg 30 mg 45 mg
Once / twice daily, with food - breakfast and evening meal Once / twice daily with food - breakfast and evening meal Once daily
GLP-1 Analogue
DPP-4 Inhibitor
Sitagliptin (Januvia) - Caution with Digoxin Saxagliptin (Ongylza) Vildagliptin (Galvus) with Metformin Vildagliptin (Galvus) with Sulphonylurea Repaglinide (Novonorm)
Nateglinide (Starlix)
Acarbose (Glucobay) Sitagliptin & Metformin (Janumet) Vildagliptin & Metformin (Eucreas) Pioglitazone & Metformin (Competact)
5 mcg 10 mcg 0.6 mgs Increase after 1/52 to 1.2 mg 100 mg 5 mg 50 mg 50 mg 0.5 mg 1 mg 2 mg 60 mg 120 mg 180 mg 50 mg 100 mg 50 mg / 850 mg 50 mg / 1000 mg 50 mg / 850 mg 50 mg / 1000 mg 15 mg / 850 mg
10 mcg BD 1.8 mg
Twice daily SC injection prior to breakfast & evening meal Once daily SC injection
Hepatic impairment Renal impairment Macular oedema Osteoporosis Cardiovascular disorders Liver failure Renal impairment, Severe GI disease Cachexia Renal impairment Liver impairment
Once daily Twice daily Once daily - with breakfast Before each meal
180 mg TDS
1 - 3 times daily with food 1 tablet twice daily with breakfast and evening meal
Little effect on reducing blood glucose levels See individual agents above
* Contrast studies Metformin should be stopped on day of contrast study if normal kidney function (48 hours before if abnormal kidney function ie Creatinine > 135 OR Egfr < 60ml/min) and only restarted 48 hours after study, if repeat U&E post contrast remains normal or unchanged.